2022/3025(DEA)
Allowing the use of nicotinamide riboside chloride as a source of niacin in food for special medical purposes and total diet replacement for weight control
Basic information
2022/3025(DEA)
DEA - Delegated acts procedure
Supplementing 2011/0156(COD)
Subject
3.10.10 Foodstuffs, foodstuffs legislation
4.60.04.04 Food safety
Status
Procedure completed - delegated act enters into force
Key players
-
European Parliament
Committee responsible Rapporteur Appointed
Key events
| Date | Event | Reference | Summary |
|---|---|---|---|
| 16/12/2022 | Non-legislative basic document published | C(2022)09048 | |
| 16/12/2022 | Initial period for examining delegated act 2.0 month(s) | ||
| 18/01/2023 | Committee referral announced in Parliament | ||
| 24/02/2023 | Delegated act not objected by Parliament |
Technical information
| Procedure | Information |
|---|---|
| Procedure reference | 2022/3025(DEA) |
| Procedure type | DEA - Delegated acts procedure |
| Nature of procedure | Examination of delegated act |
| Supplementing 2011/0156(COD) | |
| Stage reached in procedure | Procedure completed - delegated act enters into force |
| Committee dossier |
ENVI/9/10994
|
Documentation gateway
-
Document type Reference Date Summary Non-legislative basic document C(2022)09048 16/12/2022